Skip to main content
. Author manuscript; available in PMC: 2014 Nov 10.
Published in final edited form as: J Control Release. 2013 May 3;171(3):349–357. doi: 10.1016/j.jconrel.2013.04.018

Figure 8.

Figure 8

Accumulation of NLC in the lungs and other organs. (A) Organ distribution of fluorescently labeled (Cy5.5) NLC in mice after i.v. (left) and inhalation (right) administration. (B) Distribution of fluorescently labeled (Cy5.5) non-targeted and LHRH-tumor targeted NLC in mouse lungs bearing human lung cancer. (C) Distribution of fluorescently labeled (Cy5.5) LHRH-tumor - targeted (NLC-LHRH) in mouse lungs bearing human lung tumor cells (tumor and non-tumor tissues; bright field and fluorescence microscope images; red color represents distribution of NLC-LHRH in tumor and non-tumor lung tissues).